S054 LGBTQ/SGM Health in Dermatology: Essentials and Updates
DESCRIPTION
This session aims to better enable dermatologists to provide medically appropriate, culturally sensitive, and culturally humble care to LGBTQ/SGD persons. Covering basic as well as advanced knowledge domains while emphasizing the latest research in LGBTQ/SGD healthcare, topics include core terminology and fundamental concepts, dermatological conditions that uniquely impact the LGBTQ/SGD population, medical and procedural sexual and gender diverse dermatology, and considerations related to broader diversity, equity, and inclusion efforts as dermatologists work to establish safe, welcoming, and affirming spaces for this population.
LEARNING OBJECTIVES
Identify and outline basic concepts of sex and gender as well as fundamental and core terminology used to describe, characterize, and study the sexual and gender diverse (SGM) population.
Summarize and discuss LGBTQ/SGM-related health disparities, including dermatology-related and overall health disparities, as well as general approaches to affirming care and establishing a safe space for LGBTQ/SGM individuals. Describe common skin concerns in this population (both medical and procedural) and their management. Describe common skin concerns in this population (both medical and procedural) and their management.
Summarize and discuss screening and prevention of disease among LGBTQ/SGM individuals. Identify opportunities for collaboration and co-management with other subspecialties in the context of patient-centered care and individual goals.
SCHEDULE
9:00 AM
Basics of a Changing Landscape: Concepts & Terminology
Jon Klint Peebles, MD, FAAD
9:20 AM
Sexual and Gender Diversity in the Dermatology Physician Workforce and Training Pipeline
Matthew David Mansh, MD, FAAD
9:40 AM
The ABCs of LGBT: How to teach inclusiveness to everyone from residents to staff
Steven Daniel Daveluy, MD, FAAD
10:00 AM
Pre and Post Exposure Prophylaxis: What a dermatologist should know
John Zampella, MD, FAAD
10:20 AM
Acne treatment in transgender patients
Howa Yeung, MD, FAAD
10:40 AM
Break
10:45 AM
Hair and hormones: Too much or too little
Carla Ximena Torres Zegarra, MD, FAAD
11:15 AM
Sexually Transmitted and Difficult to Treat Dermatophytosis
Avrom Caplan, MD, FAAD
11:45 AM
Question and Answer
DIRECTOR
John Zampella, MD, FAAD
CO-DIRECTOR
Daniel Yanes, MD, FAAD
SPEAKERS
Avrom Caplan, MD, FAAD
Steven Daniel Daveluy, MD, FAAD
Matthew David Mansh, MD, FAAD
Jon Klint Peebles, MD, FAAD
Carla Ximena Torres Zegarra, MD, FAAD
Howa Yeung, MD, FAAD
HANDOUTS
DISCLOSURES
Avrom Caplan, MD, FAAD
Novartis – Consultant (1099 relationship)(Fees); Priovant Therapeutics – Advisory Board(Fees), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding);
Steven Daniel Daveluy, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Insmed – Investigator(Grants/Research Funding); Leo Pharma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); UCB – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria);
Matthew David Mansh, MD, FAAD
No financial relationships exist with ineligible companies.
Jon Klint Peebles, MD, FAAD
Kaiser Permanente – Employee(Salary);
Carla Ximena Torres Zegarra, MD, FAAD
No financial relationships exist with ineligible companies.
Daniel Yanes, MD, FAAD
Merz Aesthetics – Consultant (1099 relationship)(Honoraria);
Howa Yeung, MD, FAAD
American Academy of Dermatology – Independent Contractor(Fees); Department. of Veterans Affairs – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Other(Residency/Fellowship Program Funding); JAMA – Independent Contractor(Fees); L'Oreal – Advisory Board(Honoraria); National Eczema Association – Investigator(Grants/Research Funding); National Institutes of Health – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria); Priovant Therapeutics – Investigator(Grants/Research Funding); Sanofi Genzyme – Advisory Board(Honoraria);
John Zampella, MD, FAAD
Arcutis Biotherapeutics – Advisory Board(Honoraria); Dermavant Sciences – Advisory Board(Honoraria); Ferndale Laboratories, Inc. – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria); Johnson & Johnson Consumer Products Company – Advisory Board(Honoraria); Merck – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); Veradermics – Advisory Board(Honoraria);